Bristol Myers Squibb
AstraZeneca opens new global strategic R&D centre in US
The new centre will be home to nearly 2,000 world-class researchers and scientists
Bristol Myers Squibb announces new $2.3bn campus in the US
Texas has been chosen as the site for a new, state-of-the-art multi-modal manufacturing campus
Bristol Myers Squibb’s New Drug Application for mezigdomide accepted by FDA
Mezigdomide improves progression-free survival in patients with relapsed or refractory multiple myeloma
Bristol Myers Squibb and SystImmune announce phase 3 results for antibody-drug conjugate
The drug showed improvements in overall survival and progression-free survival in two cancers
Novartis breaks ground on US radioligand therapy site
The construction is part of the company’s investment in US research and manufacturing
Bristol Myers Squibb evolves and expands multiple myeloma programme
Created in 2016, the Standing in the Gaap programme aims to advance more equitable care
BMS’ Opdivo gets expanded FDA and EU approval for Hodgkin lymphoma
This type of cancer is the most common one diagnosed in teenagers
Bristol Myers Squibb’s Sotyktu approved by US FDA for psoriatic arthritis
Sotyktu is the first TYK2 inhibitor approved for active psoriatic arthritis
Genentech increases investment to $2bn for US manufacturing site
Roche and Genentech have a current commitment of $50bn for US manufacturing
BMS announces affordable drug price agreement with US government
The company will provide Eliquis, its oral blood thinner, free of charge to Medicaid
Novartis announces plans for new US manufacturing hub
The US hub is expected to create 700 new jobs by 2030
Lilly to invest $1.2bn in Puerto Rico manufacturing site
The investment will strengthen Lilly’s US manufacturing network